The US FDA has approved Wako Diagnostics’s new LBA AFP-L3 test system. It is intended for the risk assessment of developing hepatocellular carcinoma (HCC), liver cancer in patients with chronic liver ...
Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S. Starting in April, providers with a Quest account will be able to order ...
This retrospective analysis examined real-world data from ctDNA testing on 125 patients with HCC (721 plasma samples) undergoing curative-intent treatments and SOC management. Patients were divided ...
Researchers have recently created a blood test that can detect liver disease years before symptoms ever develop, helping pave the way for the diagnosis of diseases such as cirrhosis and liver cancer ...
Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results